BioXcel Therapeutics, Inc. is an innovative clinical-phase biopharmaceutical company headquartered in New Haven, Connecticut, that leverages artificial intelligence to enhance drug discovery and development in neuroscience and immuno-oncology. With a robust pipeline aimed at addressing significant unmet medical needs, BioXcel is committed to transforming patient care through cutting-edge therapeutics. The company's unique approach combines advancements in AI with deep scientific expertise, positioning it at the forefront of a rapidly evolving healthcare landscape.